Your browser doesn't support javascript.
loading
Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.
D'Armiento, Jeanine; Shiomi, Takayuki; Marks, Sarah; Geraghty, Patrick; Sankarasharma, Devipriya; Chada, Kiran.
Afiliação
  • D'Armiento J; Center for Pulmonary Disease, Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York. jmd12@cumc.columbia.edu.
  • Shiomi T; Center for Pulmonary Disease, Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York.
  • Marks S; Center for Pulmonary Disease, Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York.
  • Geraghty P; Center for Pulmonary Disease, Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York.
  • Sankarasharma D; Department of Biochemistry, Rutgers-Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.
  • Chada K; Department of Biochemistry, Rutgers-Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.
Cancer Res ; 76(4): 844-54, 2016 Feb 15.
Article em En | MEDLINE | ID: mdl-26837766

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína HMGA2 / Serina-Treonina Quinases TOR / Haploinsuficiência / Carcinogênese Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína HMGA2 / Serina-Treonina Quinases TOR / Haploinsuficiência / Carcinogênese Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article